GLP-1 TREATMENT IN DELHI

What GLP-1 medicines actually are

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after eating. It does several useful things at once: it signals fullness to the brain, slows how quickly the stomach empties, and prompts the pancreas to release insulin when blood glucose rises.

GLP-1 receptor agonists are medicines that mimic this hormone but persist far longer in the body, which is why most are taken once weekly rather than after every meal.

Tirzepatide goes further, activating both GIP and GLP-1 receptors. This dual action is reflected in the trial data, where it produces the largest average weight reductions of any injectable studied to date.

These are not appetite suppressants in the older sense. They restore a satiety signal rather than overriding hunger, which is why patients describe food preoccupation quietening rather than feeling unable to eat.

Why they work when diets have not

Most patients arriving at our clinic have lost weight before, sometimes repeatedly, and regained it. That pattern is not a character failure; it reflects how the body defends against weight loss.

When you lose weight, hunger and satiety hormones shift in a direction that promotes intake and conserves energy. Resting metabolic rate falls. These adaptations persist for a long time, which is why maintaining a loss is harder than achieving it.

GLP-1 medicines act directly on that hormonal signalling. Patients consistently describe the same experience: the constant mental noise about food quietens, and portions that once felt inadequate now feel sufficient.

That is why a calorie deficit becomes achievable without the daily willpower battle that defeats most diets.

Who qualifies in Delhi

The established framework is a BMI of 30 or above, or 27 or above where a weight-related condition is present — type 2 diabetes, prediabetes, hypertension, high cholesterol, obstructive sleep apnoea, PCOS, fatty liver disease or weight-bearing joint disease.

For Indian patients this framework needs care. Research consistently shows South Asian populations develop metabolic complications at lower BMI than European populations, because of differences in body fat distribution and visceral fat.

Several guidelines therefore apply lower thresholds for South Asian patients. In practice we assess waist circumference and metabolic markers alongside BMI rather than treating BMI as the sole gatekeeper.

A patient at BMI 28 with central obesity, raised HbA1c and fatty liver is a very different clinical picture from a patient at BMI 28 with entirely normal markers.

Who should not take them

A personal or family history of medullary thyroid carcinoma, or of Multiple Endocrine Neoplasia syndrome type 2, is an absolute exclusion. This requires knowing your family history, which some patients need to check before their appointment.

A history of pancreatitis rules out treatment. So does pregnancy, breastfeeding, or planned conception in the near term — these medicines are stopped a defined period before conception.

Type 1 diabetes is a different condition and this is not a substitute for insulin. Severe kidney impairment, significant gastrointestinal disease including gastroparesis, and active disordered eating all require a different approach.

If you do not qualify, a doctor should say so plainly and explain what would suit you instead rather than prescribing anyway.

Patient outcomes from supervised programmes at our clinic, published with consent and with faces obscured for privacy. Individual results vary.

Your first consultation: what to expect

The first appointment is a clinical assessment, not a sales conversation. Expect questions covering your weight history from childhood, every diet or medication you have tried and what happened, and why previous attempts ended.

Your full current medication list is reviewed, including anything prescribed elsewhere and any supplements. Family history of diabetes, thyroid disease and the exclusions above is taken carefully.

You will be screened for weight-related conditions — sleep apnoea symptoms, PCOS in women, joint problems, reflux — because these change both eligibility thresholds and treatment priorities.

Height, weight, BMI, waist circumference and blood pressure are recorded as a baseline you will be measured against at every subsequent review.

Baseline blood work and why it matters

Blood work typically covers HbA1c or fasting glucose, thyroid function, liver function, kidney function, lipid profile, and vitamin D and B12. Some patients need additional tests based on their history.

This serves three purposes. It identifies conditions that make treatment unsafe. It establishes a baseline so improvement can be measured objectively rather than by weight alone. And it detects existing deficiencies that will worsen once intake falls.

Undertreated hypothyroidism, for example, makes weight loss disproportionately difficult and is worth correcting before or alongside treatment rather than discovering months later during a plateau.

Any clinic prescribing these medicines without baseline blood work is not managing your safety, and that is a reason to look elsewhere regardless of price.

How the dose schedule works

Treatment always begins at the lowest weekly dose, regardless of your weight or your goal. That starting dose exists to let your digestive system adapt before the appetite effect is strengthened.

You remain at each level for a defined period, commonly around four weeks, before an increase is considered. Progression is never automatic — at each review your team assesses weight trend, side effect tolerance, nutritional intake and any new symptoms.

If you are struggling, the dose holds rather than rises. A hold is a normal clinical tool, not a setback. Most patients who pause for a few extra weeks go on to tolerate the next step comfortably.

Not everyone reaches the maximum dose, and not everyone needs to. The right dose is the lowest one producing a good result you can tolerate — which also costs less.

Learning to inject

You are taught to self-inject in person and given the chance to practise before doing it alone. The medicine goes into the fat layer just under the skin — abdomen, front of thigh, or back of upper arm.

Rotate the site each week rather than using the same spot, which prevents lumps and inconsistent absorption. Let the pen reach room temperature before injecting; cold medicine stings noticeably more, and this single step makes the biggest practical difference.

The needle is very fine, and most patients report the anticipation is considerably worse than the injection itself. Needle anxiety is common and worth raising rather than struggling with silently.

Pens require refrigeration and must never be frozen. A frozen pen is discarded, not thawed and used.

What the first month feels like

Most patients notice appetite changes within the first one to two weeks. Meals feel adequate sooner, and the background preoccupation with food quietens. That subjective change is the meaningful early signal.

Weight movement in month one is typically modest and partly fluid. Some patients see two or three kilograms, others considerably less. Neither predicts the eventual outcome, because you are still on a starting dose designed to build tolerance rather than drive loss.

Side effects are usually most noticeable in the first few days after each injection, then settle. Nausea, reduced appetite and altered bowel habit are expected.

Judging treatment on month one is the single most common avoidable mistake, and the most common reason patients stop before reaching a dose that would have worked.

Months two to six: what actually happens

By month two or three you have stepped up at least once and the appetite effect is stronger. This is usually when a consistent downward trend becomes visible on a four-week trend line.

Clothes frequently change before the scale reflects it, particularly if you have started resistance training, which shifts body composition while adding a small amount of lean mass.

Months four to six are typically the steadiest phase, with most patients at or near their effective dose. Metabolic markers commonly improve alongside weight — glucose, HbA1c, blood pressure, triglycerides and liver markers.

Many patients report the improvements they value most are not on the scale: sleep quality, joint pain, mobility, energy and confidence.

Realistic results

Published trials report average total body weight reductions of roughly 15% for high-dose semaglutide over about 68 weeks, and up to roughly 20% for high-dose tirzepatide over about 72 weeks, both alongside structured lifestyle support.

An average is a midpoint. Roughly a third of trial participants achieved substantially more; a proportion achieved considerably less. Neither group did anything wrong.

Those trials also delivered lifestyle support that many real-world patients never receive, which is a large part of why supervised programmes outperform prescriptions alone.

Your doctor should discuss a realistic range for your own profile rather than quoting a headline figure from a study.

Side effects and how they are managed

The overwhelming majority are digestive: nausea, reduced appetite, constipation, diarrhoea, reflux and burping. They are usually mild to moderate, strongest in the days following a dose increase, and settle as the body adapts.

Practical management works. Eat smaller amounts more often, stop at the first sign of fullness rather than finishing the plate, eat slowly, and avoid fatty or fried food in the days after an increase. Hydration and gradual fibre prevent most constipation.

Serious effects are uncommon but real. Severe abdominal pain radiating to the back can indicate pancreatitis; severe upper-right abdominal pain may indicate gallbladder disease. Both warrant same-day contact rather than waiting for a review.

You should receive written guidance on which symptoms need urgent contact before you start, along with a route to reach someone outside clinic hours.

Patient outcomes from supervised programmes at our clinic, published with consent and with faces obscured for privacy. Individual results vary.

Nutrition: the part that decides whether it lasts

When appetite falls sharply, what you eat matters more, not less. You may be eating half of what you previously did, so every meal has to work considerably harder nutritionally.

The specific risk is muscle. Muscle is metabolically active, and losing it lowers your resting energy expenditure, making the result harder to hold once treatment ends. Protein at every meal is the countermeasure, distributed across the day rather than concentrated at dinner.

For Delhi households this means restructuring rather than importing a template: dal, rajma, paneer, curd, eggs, soya and sattu as the centre of the plate rather than accompaniments to a large serving of rice or several rotis.

Resistance training two or three times weekly, scaled to your joints and fitness, does more to preserve lean mass than any amount of cardiovascular exercise.

What treatment costs in Delhi

These medicines are priced by strength, so your monthly cost rises as the dose escalates over the first several months. A patient who responds well at a middle dose pays considerably less than one who needs the maximum.

This is why no honest clinic can quote a single flat figure before assessing you. Ask specifically what the cost will be at the dose you are likely to need, not just the starting dose.

A programme should include consultations and scheduled reviews, baseline and follow-up blood work, injection training, a personalised diet plan with dietitian access, side-effect management and guidance on stopping. If a quote covers only the medicine, you are buying a prescription.

Because obesity is chronic, the meaningful figure is annual rather than monthly. Plan for escalation over the first three to four months and a settled cost thereafter.

Delhi NCR: consultations and access

Our clinic is at D-1/97, Basement, Lajpat Nagar 1, New Delhi 110024, open Monday to Saturday, 9:00 AM to 5:00 PM. Lajpat Nagar is accessible from across South Delhi and connects readily to Gurgaon, Noida, Faridabad and Ghaziabad.

For patients elsewhere in NCR or further afield, first consultations can be conducted by video. History, goals and suitability are assessed remotely, and blood work can be arranged locally and reviewed before prescribing.

Once treatment is established, many follow-up reviews are conducted online, which suits patients travelling from Noida or Gurgaon who would otherwise lose half a day to each appointment.

Some elements still require an in-person visit, and your doctor will be clear about which.

Warning signs when choosing a clinic

Be cautious of anywhere prescribing injectable medicines without blood work or a proper doctor consultation. That is the clearest single indicator of a clinic treating these as a retail product.

Compounded or unbranded versions circulate at lower prices. They are not quality-assured, dosing cannot be verified, and regulators in several countries have issued warnings after adverse events. We neither prescribe nor endorse them.

Guaranteed weight loss figures, pressure to buy long prepaid packages on a first visit, no dietitian involvement, and no plan for what happens when treatment ends are all meaningful gaps.

Ask what happens if you do not tolerate the medicine, and who you contact outside clinic hours. A clinic that cannot answer clearly is telling you something.

What happens when you stop

Appetite returns when the medicine is withdrawn. Published follow-up of semaglutide discontinuation reported participants regaining roughly two thirds of lost weight within about a year without continued support.

This is not a failure of the medicine. It reflects that obesity is a chronic condition with a biological basis, in the same way blood pressure rises again after stopping antihypertensives.

It is also why discontinuation should be planned and tapered with increased nutrition support and closer monitoring, rather than simply stopping when a target is reached.

Some patients continue long term, some taper to a maintenance dose, and some move to another approach. That decision is made with your doctor rather than unilaterally.

When injections are not the right route

At a BMI of 40 and above, or 35 and above with serious weight-related disease, bariatric surgery produces substantially larger and more durable results, and frequently improves type 2 diabetes, sleep apnoea and blood pressure alongside.

For patients wanting a defined, time-limited intervention without surgery, the Allurion swallowable balloon occupies stomach volume for around sixteen weeks with no anaesthesia or endoscopy.

For patients below the treatment threshold, dietitian-led weight management is the appropriate route, and prescribing an injectable would not be.

A clinic offering only injections cannot give you this comparison honestly. We offer four routes, which means we can recommend the least invasive option that will realistically work.

About Dr. Rajat Goel

Dr. Rajat Goel is a Gold Medalist surgeon with more than 25 years in practice, holding MBBS, MS, DNB and MNAMS alongside fellowships including FAIS, FICS, FACS, FMAS, FIAGES, FALS and FIMSA, with international fellowships FMIS (Singapore) and FMBS (Taiwan).

His experience spans over 2000 bariatric procedures and 17000 laparoscopic surgeries, alongside more than 1300 patients supervised on GLP-1 and dual-agonist programmes and over 500 Allurion balloon patients.

That combination matters for injectable treatment specifically. A doctor who also performs bariatric surgery can tell you honestly when injections are unlikely to be enough for your BMI.

He has published over 19 papers internationally and continues to teach in minimal access surgery.

Taking the first step

A consultation establishes whether GLP-1 treatment is appropriate for you, which medicine suits your clinical picture, what it would cost at your likely dose, and what the programme involves.

You should leave knowing all of that, and knowing what the alternatives are if injections are not right. If the honest answer is that no treatment is appropriate yet, we will tell you.

Blood work is arranged as part of the assessment, and the results are reviewed before any prescription is issued.

You can book by phone, WhatsApp or through this website, and first consultations are available in clinic or by video.

Frequently asked questions